HORIZON EUROPE
Europeo
Scope:Specific challenge: Effective health care for the rapidly growing elderly population in Europe is challenging and complex. This population is subject to frequent and numerous comorbidities, associated poly-pharmacy and impaired hepatic and renal function, as well as problems linked to access to care and compliance. In addition, while the elderly are overrepresented in terms of patient numbers, this group is underrepresented or even excluded from many clinical trials that generate the evidence-base for health care interventions.
Scope: Proposals should compare the use of currently available (pharmacological as well as non-pharmacological) healthcare interventions in the elderly (> 65 year) population (or subgroups thereof).
While there is no restriction on the diseases or interventions to be the focus of proposals, preference will be given to proposals focusing on interventions with high public health relevance, i.e. interventions addressing conditions that are particularly frequent, have a high negative impact on the quality of life of the individual and/or are associated with significant costs or where savings can be achieved.
Issu...
ver más
Scope:Specific challenge: Effective health care for the rapidly growing elderly population in Europe is challenging and complex. This population is subject to frequent and numerous comorbidities, associated poly-pharmacy and impaired hepatic and renal function, as well as problems linked to access to care and compliance. In addition, while the elderly are overrepresented in terms of patient numbers, this group is underrepresented or even excluded from many clinical trials that generate the evidence-base for health care interventions.
Scope: Proposals should compare the use of currently available (pharmacological as well as non-pharmacological) healthcare interventions in the elderly (> 65 year) population (or subgroups thereof).
While there is no restriction on the diseases or interventions to be the focus of proposals, preference will be given to proposals focusing on interventions with high public health relevance, i.e. interventions addressing conditions that are particularly frequent, have a high negative impact on the quality of life of the individual and/or are associated with significant costs or where savings can be achieved.
Issues of particular relevance for the target populations, for example, poly-pharmacy, vaccine efficacy, compliance, and under-diagnosed or untreated pain should be taken into account. Given the focus on existing interventions, proposals will aim to contribute to decisions about the discontinuation of interventions that are less effective or cost-effective than others.
A comprehensive array of clinical and safety parameters, as well as health and socio-economic outcomes (e.g. quality of life, patient mortality, morbidity, costs, and performance of the health system) for chosen populations should be assessed. Agreed core outcome sets (CSO) should be used as endpoints in conditions where they already exist, in other cases efforts should be made to agree on such COS.
Randomised controlled trials, pragmatic trials, observational studies, large scale databases and meta-analyses may be considered for this topic. The study population should address gender balance where relevant.
The Commission considers that proposals requesting a contribution from the EU of between EUR 4 and 6 million would allow this specific challenge to be addressed appropriately. Nonetheless, this does not preclude submission and selection of proposals requesting other amounts.
Expected impact:
Evidence base for more effective and safer interventions, and for enhanced compliance, in the elderly population, and the use of health technology assessment methodology in this target group. In particular: Improvement of individual patient outcomes and health outcome predictability through tailoring of interventions Improvement of guideline development for diseases and the management of comorbidities Support to regulatory guidance in this population and provision of more accurate information to patients and prescribers Type of action: Research and innovation actions
Cross-cutting Priorities:Cross-cutting Key-Enabling Technologies (KETs)Socio-economic science and humanitiesGender
ver menos
Características del consorcio
:
La ayuda es de ámbito europeo, puede aplicar a esta linea cualquier empresa que forme parte de la Comunidad Europea.
Características del Proyecto
Los costes de personal subvencionables cubren las horas de trabajo efectivo de las personas directamente dedicadas a la ejecución de la acción. Los propietarios de pequeñas y medianas empresas que no perciban salario y otras personas físicas que no perciban salario podrán imputar los costes de personal sobre la base de una escala de costes unitarios
Los otros costes directos se dividen en los siguientes apartados: Viajes, amortizaciones, equipamiento y otros bienes y servicios. Se financia la amortización de equipos, permitiendo incluir la amortización de equipos adquiridos antes del proyecto si se registra durante su ejecución. En el apartado de otros bienes y servicios se incluyen los diferentes bienes y servicios comprados por los beneficiarios a proveedores externos para poder llevar a cabo sus tareas
La subcontratación en ayudas europeas no debe tratarse del core de actividades de I+D del proyecto. El contratista debe ser seleccionado por el beneficiario de acuerdo con el principio de mejor relación calidad-precio bajo las condiciones de transparencia e igualdad (en ningún caso consistirá en solicitar menos de 3 ofertas). En el caso de entidades públicas, para la subcontratación se deberán de seguir las leyes que rijan en el país al que pertenezca el contratante
Características de la financiación
List of countries and applicable rules for funding: described in part A of the General Annexes of the General Work Programme.
Eligibility and admissibility conditions: described in part B and C of the General Annexes of the General Work Programme
Evaluation
3.1 Evaluation criteria and procedure, scoring and threshold: described in part H of the General Annexes of the General Work Programme, with the following exceptions
The thresholds for each criterion at stage 1 (of a two stage process) will be 4 and 4. The cumulative threshold will be 8.
The thresholds for each criterion at stage 2 (of a two stage process) will be 4, 4 and 3. The cumulative threshold will be 12.
If a proposal fails to achieve the threshold for a criterion at any stage, the evaluation of the proposal will be stopped.
The median of individual evaluator scores may be used at stage 1 to determine the consensus score and when appropriate, the resulting consensus report may comprise elements of these individual reports, or standard phrases representative thereof.
The page limit for stage 1 proposals is 7 pages (including the title page).
3.2 Guide to the submission and evaluation process
Proposal page limits and layout: Please refer to Part B of the standard proposal template.
Indicative timet... Please read carefully all provisions below before the preparation of your application.
List of countries and applicable rules for funding: described in part A of the General Annexes of the General Work Programme.
Eligibility and admissibility conditions: described in part B and C of the General Annexes of the General Work Programme
Evaluation
3.1 Evaluation criteria and procedure, scoring and threshold: described in part H of the General Annexes of the General Work Programme, with the following exceptions
The thresholds for each criterion at stage 1 (of a two stage process) will be 4 and 4. The cumulative threshold will be 8.
The thresholds for each criterion at stage 2 (of a two stage process) will be 4, 4 and 3. The cumulative threshold will be 12.
If a proposal fails to achieve the threshold for a criterion at any stage, the evaluation of the proposal will be stopped.
The median of individual evaluator scores may be used at stage 1 to determine the consensus score and when appropriate, the resulting consensus report may comprise elements of these individual reports, or standard phrases representative thereof.
The page limit for stage 1 proposals is 7 pages (including the title page).
3.2 Guide to the submission and evaluation process
Proposal page limits and layout: Please refer to Part B of the standard proposal template.
Indicative timetable for evaluation and grant agreement:
Information on the outcome of two-stage evaluation: maximum 5 months from the final date for submission.
Signature of grant agreements: maximum 3 months from the date of informing successful applicants.
Provisions, proposal templates and evaluation forms for the type(s) of action(s) under this topic:
Research and Innovation Action:
Specific provisions and funding rates
Annotated Model Grant Agreement
pdf templates for part B of the proposal (called technical annex) and an evaluation form for this call are available under on the call page under “call documents”. If you want the Technical Annex template in word format you need to register for submission and download it from the system.
In addition, on the same page a specific template for essential information for clinical trials/studies/investigations Applicants are requested to consult the information for clinical trials at stage one even though it has to be completed only at stage 2 and to be uploaded under call specific questions in the table of contents.
Additional provisions:
Horizon 2020 budget flexibility
Classified information
Open access must be granted to all scientific publications resulting from Horizon 2020 actions, and proposals must refer to measures envisaged. Where relevant, proposals should also provide information on how the participants will manage the research data generated and/or collected during the project, such as details on what types of data the project will generate, whether and how this data will be exploited or made accessible for verification and re-use, and how it will be curated and preserved.
Información adicional de la convocatoria
Otras ventajas
Ayudas Similares
| Abierta
| Próximamente
| Abierta